NDAORALTABLET, EXTENDED RELEASE
Approved
Sep 2023
Lifecycle
Growth
Competitive Pressure
8/100
Mechanism of Action
5HT1A receptors.
Indications (1)
Loss of Exclusivity
LOE Date
Sep 2, 2030
54 months away
Patent Expiry
Sep 2, 2030
Exclusivity Expiry
Sep 22, 2028
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 7538116 | Sep 2, 2030 | U-3699 |